Two HSS studies received awards from the American Society of Regional Anesthesia and Pain Medicine. One looked at the prevalence of CBD use in patients scheduled for sports medicine surgery. The other compared the need for opioid medication after robotic, computer-assisted or manual hip replacement.

Many mitochondrial diseases have been difficult to study and treat due to the inherent challenges in accessing mitochondrial DNA (mtDNA). Now, researchers from Japan have optimized mitochondrial-targeted compounds that can selectively modify the ratio of normal versus mutant mtDNA in patient-derived stem cells. This technology enables the creation of research models with varying mutation loads and demonstrates potential as a therapeutic strategy for reducing mutant mtDNA in patients, offering hope for mitochondrial disease treatment.